Paul V. Majkowski focuses on complex mass toxic tort litigation, including coordinating with attorneys in Korea, France, New Zealand, and Canada regarding a set of related controversies with matters in those jurisdictions.

Paul’s practice includes defending claims for personal injury and property damage purportedly arising out of alleged exposure to herbicides, pesticides, and other chemicals. He is experienced in alleged dioxin exposure cases, and routinely engages with epidemiologists, toxicologists and biostatisticians, as well as medical clinicians and scientists in other disciplines.

In addition to his focus on toxic tort and product liability, Paul has litigated and arbitrated a broad range of other disputes over the course of his more than 30 years in practice. His experience encompasses insurance matters (environmental and mass tort coverage, first-party property insurance, etc.), other tort and personal injury defense, and commercial disputes.

Paul is active in the International Association of Defense Counsel as a Vice Chair in the Toxic & Hazardous Substances Committee, along with involvement with the American Bar Association Litigation Section’s Mass Tort Committee and the Jagiellonian Law Society. He has published on a variety of issues involving mass torts, toxic torts and related science, international toxic tort litigation, and the recognition of foreign judgments, and has presented at seminars sponsored by IADC, ABA, ACI, and the US-Korea Law Foundation.

A former Editor in Chief of the St. John’s Law Review, Paul has served as an officer and director in the Nassau and Manhattan chapters of the law school’s alumni association. He also participates in the ABA’s National Appellate Advocacy Competition as a moot court judge and brief grader.

Paul devotes significant time to the Lymphoma Research Foundation, and in 2025, was elected to the Foundation’s Board of Directors. A long-time volunteer, he received the Lymphoma Research Foundation’s Distinguished Service Award in 2016; during his tenure, he has served as an LRF Ambassador and  president of the Foundation’s New York City chapter. Paul also currently serves an appointment as an FDA Patient Representative and has sat on several panels of the FDA Oncologic Drug Advisory Committee. Paul volunteers pro bono with the Cancer Advocacy Project of the New York City Bar Association.